Zacks Investment Research on MSN

CRISPR Therapeutics AG (CRSP) is a trending stock: Facts to know before betting on it

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...
Zacks Investment Research on MSN

CRISPR Therapeutics AG (CRSP) stock declines while market improves: Some information for investors

In the latest close session, CRISPR Therapeutics AG (CRSP) was down 8.7% at $55.52. The stock fell short of the S&P 500, ...
Zacks.com on MSN

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $54.65, marking a -1.57% move from the previous day. This move lagged the S&P 500's daily gain of 0.5%. On the other hand, the ...
Nasdaq

Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50%

Cathie Wood aims to identify innovators and invest in them early in their stories. Wood has been regularly adding to her position in this stock, and it’s one of her top holdings. 10 stocks we like ...